A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...

Researchers from USask have identified a potential target for eliminating breast cancer cells. The team was led by Dr. Franco ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

An innovative blood cancer treatment regimen could extend remission by seven months on average, according to a clinical trial ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T ...

Scientists have created a new nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. To make the therapy even ...

FDA approves Zynyz for advanced anal cancer, marking a breakthrough for the 10,000 diagnosed annually—including actress ...

Despite groundbreaking advances in pediatric cancer research, many promising therapies never reach the children who need them most. Catherine Bollard, MD, is senior vice president and chief research ...

With the future of her cancer treatment in limbo, Natalie Phelps doesn’t know how much longer she can wait. Last month, after months of seeking treatment options for her colorectal cancer ...

But he quickly integrated applying sunscreen into his daily routine, calling it his way of showing “gratitude” after his cancer scare. “Skin care is a more palatable and accepted term and ...